Defining the structure of membrane-bound human blood coagulation factor Va
- PMID: 17949476
- DOI: 10.1111/j.1538-7836.2007.02810.x
Defining the structure of membrane-bound human blood coagulation factor Va
Abstract
Background: Blood coagulation factor (F) Va is the essential protein cofactor to the serine protease FXa. Factor Va stimulates the thrombin-to-prothrombin conversion by the prothrombinase complex, by at least five orders of magnitude. Factor Va binds with very high affinity to phosphatidylserine containing phospholipid membranes, which allows the visualization of its membrane-bound state by transmission electron microscopy (EM).
Methods: In this paper we present an averaged three-dimensional structure of FVa molecules attached to phosphatidylserine containing lipid tubes, as determined by EM and single particle analysis. The low-resolution FVa three-dimensional structure is compared with the available atomic models for FVa.
Results: The experimental data are combined with the most suitable atomic model and a membrane-bound FVaEM model is proposed that best fits the protein density defined by EM. In the FVaEM model, the C1 and C2 membrane-binding domains are juxtaposed onto the membrane surface and the model geometries indicate a deeper insertion of both C domains into the lipid bilayer than has been previously suggested.
Conclusion: The present structure is a first step towards a higher-resolution experimental structure of a human FVa molecule in its membrane-bound conformation, allowing the visualization of individual domains within FVa and its association with the membrane.
Similar articles
-
A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex.Blood. 2008 Oct 1;112(7):2795-802. doi: 10.1182/blood-2008-02-138941. Epub 2008 Jun 27. Blood. 2008. PMID: 18587009 Free PMC article.
-
Prothrombin contributes to the assembly of the factor Va-factor Xa complex at phosphatidylserine-containing phospholipid membranes.J Biol Chem. 1995 Nov 10;270(45):26883-9. doi: 10.1074/jbc.270.45.26883. J Biol Chem. 1995. PMID: 7592932
-
Cryo-EM structure of coagulation factor Va bound to activated protein C.Blood. 2025 Jun 26;145(26):3166-3177. doi: 10.1182/blood.2025028476. Blood. 2025. PMID: 40324068 Free PMC article.
-
Factor Va-factor Xa interactions: molecular sites involved in enzyme:cofactor assembly.Scand J Clin Lab Invest Suppl. 2002;237:5-11. doi: 10.1080/003655102762377439. Scand J Clin Lab Invest Suppl. 2002. PMID: 12570161 Review.
-
Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding.J Thromb Haemost. 2019 Aug;17(8):1229-1239. doi: 10.1111/jth.14487. Epub 2019 Jun 17. J Thromb Haemost. 2019. PMID: 31102425 Free PMC article. Review.
Cited by
-
Domain organization of membrane-bound factor VIII.Biopolymers. 2013 Jul;99(7):448-59. doi: 10.1002/bip.22199. Biopolymers. 2013. PMID: 23616213 Free PMC article.
-
Lack of recombinant factor VIII B-domain induces phospholipid vesicle aggregation: implications for the immunogenicity of factor VIII.Haemophilia. 2014 Sep;20(5):723-31. doi: 10.1111/hae.12421. Epub 2014 Apr 21. Haemophilia. 2014. PMID: 24750465 Free PMC article.
-
Factor VIII and Factor V Membrane Bound Complexes.Subcell Biochem. 2021;96:153-175. doi: 10.1007/978-3-030-58971-4_2. Subcell Biochem. 2021. PMID: 33252728 Review.
-
Development of a novel and viable knock-in factor V deficiency murine model: Utility for an ultra-rare disease.PLoS One. 2025 Jun 2;20(6):e0321864. doi: 10.1371/journal.pone.0321864. eCollection 2025. PLoS One. 2025. PMID: 40455764 Free PMC article.
-
Development and Characterization of a Factor V-Deficient CRISPR Cell Model for the Correction of Mutations.Int J Mol Sci. 2022 May 22;23(10):5802. doi: 10.3390/ijms23105802. Int J Mol Sci. 2022. PMID: 35628611 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous